A Trial of TQB2868 Plus Platinum-based Chemotherapy With or Without Bevacizumab in the First-line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer

DRUG: TQB2868 injection
DRUG: Paclitaxel injection
DRUG: Cisplatin injection
DRUG: Carboplatin injection
DRUG: Bevacizumab injection

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Slow progress in development, the sponsor decided to withdraw and no longer proceed.

Conditions

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.